Blood sugar control: Tirzepatide helps lower blood sugar levels by stimulating the release of insulin, which helps move glucose into cells for energy, and by reducing the production of glucose in the liver
Lumbar disc degeneration and segmental instability: a comparison of magnetic resonance images and plain radiographs of patients with low back pain
Aqueous cells were absent at 96 h and 120 h after injury in the 2 g and 2 ng BPC 157 treated groups, respectively
In clinical practice, the addition of BPC-157 has been associated with improved rather than worsened GI tolerance, consistent with BPC-157's known gastroprotective pharmacology
Many users report increased energy and slight weight changes within the first few weeks
The evidence is still early Most peptides explored for kidney support, including BPC-157 and thymosin beta-4, are not FDA-approved for treating kidney disease